Bioventus Inc. - Form 4 Filing

Anthony D'Adamio, SVP & General Counsel of Bioventus Inc., reported transactions on April 10, 2026. D'Adamio acquired 9,925 shares of Class A Common Stock through the settlement of 9,925 Restricted Stock Units (RSUs) at a price of $0.00 per share. Following this acquisition, D'Adamio disposed of 4,312 shares of Class A Common Stock at a price of $9.06 per share. The RSUs vest in four equal annual installments starting from April 10, 2023, contingent upon continued service. D'Adamio directly owns 153,655 shares of Class A Common Stock after these transactions.